Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with ageBiological Sciences Published on 2023-03-142024-09-05 Journal: Proceedings of the National Academy of Sciences of [Category] update2024, [키워드] age groups cross-protection human coronavirus OC43 SARS-CoV-2 T cell specificity [DOI] 10.1073/pnas.2220320120 PMC 바로가기 [Article Type] Biological Sciences
Research Note: Effect of a live Salmonella Enteritidis vaccine against Salmonella Pullorum infection in breeder chickensarticle Published on 2023-02-282024-09-01 Journal: Poultry Science [Category] 살모넬라증, [키워드] breeder chicken cross-protection live vaccine Salmonella Enteritidis Salmonella Pullorum [Article Type] article
Anti-Arbovirus Antibodies Cross-React With Severe Acute Respiratory Syndrome Coronavirus 2Article Published on 2022-12-212023-07-10 Journal: Microbiology Spectrum [Category] COVID19(2023년), [키워드] arbovirus Chikungunya virus cross-protection dengue virus Neutralizing antibodies SARS-CoV-2 serological cross-reactivity. [DOI] 10.1128/spectrum.02639-22 PMC 바로가기
SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in MiceArticle Published on 2022-11-012022-11-15 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome ancestral antibody Australia challenge coronavirus coronavirus disease COVID-19 cross-protection cross-reactivity Delta elicited homologous immunogenicity Infection K18-hACE2 K18-hACE2 mice mice Neutralizing Neutralizing antibodies neutralizing antibody omicron Omicron BA.1 remained respiratory infections SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variants severe acute respiratory syndrome coronavirus 2 Strains vaccine-preventable diseases viruses zoonoses [DOI] 10.3201/eid2811.220718 PMC 바로가기
Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune responseArticle Published on 2022-10-012022-11-15 Journal: Journal of internal medicine [Category] 진단, [키워드] acute respiratory syndrome Adults adverse effect adverse event adverse events Ageusia angiotensin-converting enzyme 2 Anosmia Bacillus BCG center clinical clinical evolution clinical trial convalescence convalescent coronavirus coronavirus disease COVID-19 cross-protection double-blind evaluated Evolution expected Follow-up humoral humoral immune response IgG Immunoglobulin immunomodulation induce lesions Local modulation multicenter N protein neutralization neutralize NNT offer Other outcome Outpatient Patient Placebo placebo-controlled placebos prevented Primary outcome proportion Randomized receptor recipient Safe Safety SARS-CoV-2 serum Seven severely ill patient significantly higher South America statistically significant systemic adverse effects treat university Vaccine viral disease virus [DOI] 10.1111/joim.13523 PMC 바로가기
Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigensSARS-CoV-2 항체와 다른 병원체, 백신, 식품 항원의 반응Article Published on 2022-09-232022-11-15 Journal: Frontiers in Immunology [Category] SARS, 백일해, 진단, 파상풍, [키워드] antibodies antibody Antigen antigens autoantigen B cell Bacteria Bacterial BCG Blood casein Combination COVID-19 cross-protection cross-react cross-reactive antibody cross-reactivity DTaP elicit elicited experiment food antigens herpesviruses homology human tissues immune immune response immune system Immunity investigated memory T molecular molecular mimicry monoclonal monoclonal antibody pathogen Pathogens peptide polyclonal antibody Proteins reaction reactivity SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 spike protein shown similarity the SARS-CoV-2 virus Vaccine vaccine antigen Vaccines Viral antigen viruses [DOI] 10.3389/fimmu.2022.1003094 PMC 바로가기
Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants감마 SARS-CoV-2에 대한 혈장 및 기억 항체 반응은 다른 변이체에 대해 제한된 교차 보호를 제공합니다Article Published on 2022-09-052022-09-11 Journal: The Journal of Experimental Medicine [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus antibody Antibody Response Beta class Cohort coronavirus cross-protection Delta elicited Epitopes evade exposure to Gamma Hospitalized implication individuals infected individual infected individuals Infection infections memory memory B cell memory B cells memory response monoclonal antibodies neutralization neutralize neutralized Neutralizing activity Neutralizing antibodies neutralizing antibody omicron other variant other variants plasma provide pseudotyped pseudovirus pseudoviruses respiratory SARS-CoV-2 SARS-CoV-2 spike protein severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly lower Spike protein vaccination variant variant-specific vaccine variant-specific vaccines variants variants of concern virus viruses Wuhan Wuhan-Hu-1 [DOI] 10.1084/jem.20220367 PMC 바로가기 [Article Type] Article
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinationsArticle Published on 2022-09-022022-11-16 Journal: Communications Biology [Category] SARS, 변종, [키워드] antibody Antibody Response booster dose Course COVID-19 COVID-19 patient cross-protection delta variant drastic reduction elicited ENhance evaluate Heterologous highest homologous Immunity mRNA vaccine Mutation natural infection neutralization capacity neutralize omicron Patient regimen replaced SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 virus serum sample survivor susceptibility tested the spike protein vaccinated individual vaccination Vaccine vaccinee variant wild-type virus [DOI] 10.1038/s42003-022-03849-0 PMC 바로가기
Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza virusesArticle Published on 2022-09-022022-10-06 Journal: Nature Communications [Category] Fulltext, 신종인플루엔자, 진단, [키워드] analyses antibody antiviral drug benefit chimeric conserved cross-neutralization cross-neutralizing cross-protection eight engage epitope overlapping Evidence H1N1 H5N1 identification in vivo Influenza influenza vaccines Influenza virus mAb molecular monoclonal antibody neutralization Neutralizing activity offer pandemic receptor binding site residue Surface glycoprotein target Tolerance Vaccine viral challenge virus virus entry viruses [DOI] 10.1038/s41467-022-32926-5 PMC 바로가기 [Article Type] Article
Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccinationArticle Published on 2022-09-022022-11-15 Journal: Frontiers in Cellular and Infection Microbiology [Category] SARS, 진단, 치료기술, [키워드] Analysis anti-HCoV-OC43 anti-nucleoprotein anti-RBD antibodies antibody binding chemiluminescence immunoassay conducted coronavirus coronavirus vaccine correlation cross-protection cross-reactivity demonstrated detect ELISA enzyme-linked immunosorbent HCoV-229E HCoV-HKU1 HCoV-NL63 HCoV-OC43 humoral Humoral response IgG Immunity Immunoglobulin inactivated individuals influence neutralization Neutralization antibody neutralizing antibody Outbreaks performed positively correlated Protective protective immunity Protein pseudovirus S1 IgG S1 subunit SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine seasonal coronavirus seasonal human coronavirus second vaccination statistically significant vaccination Vaccine vaccinee vaccinees viral neutralization [DOI] 10.3389/fcimb.2022.978440 PMC 바로가기